Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhenzhu Wan (Pearl Pills) is a traditional Tibetan medicine developed and manufactured by Qinghai Jiumei Tibetan Medicine. It is an approved oral pill formulation used primarily in the treatment of neurological and cardiovascular disorders. In the context of Tibetan medicine, it is indicated for 'rLung' (wind) diseases, which encompass symptoms such as tremors, paralysis, facial nerve palsy, and the sequelae of stroke (cerebrovascular accidents). The formulation typically centers on pearl (Pteria martensii) as a key ingredient, combined with various other medicinal herbs and minerals intended to harmonize the nervous system and improve blood circulation. As a traditional medicine, it operates through a multi-component synergistic effect rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhenzhu Wan.